Table 1.

Baseline demographics, clinical chemistry and interval between symptom onset and baseline presentation.

Variable	POCT (n = 218)	Controls (n = 151)
	n (%) or mean ± SD	n (%) or mean ± SD
Men	121 (57.9)	83 (58.0)
Age [years]	65 ± 16	64 ± 17
Weight [kg]	80 ± 17	78 ± 17
Height	169 ± 10	169 ± 9
Body mass index [kg/m2]	28 ± 5	27 ± 6
Glucose [mmol/l]	5.9 ± 1.5	6.3 ± 2.1
Creatinine [mmol/l]	84.4 ± 29.1	84.4 ± 22.4
High-density lipoprotein [mmol/l]	1.4 ± 0.7	1.4 ± 0.5
Low-density lipoprotein [mmol/l]	2.9 ± 1.0	3.3 ± 1.0
Triglycerides [mmol/l]	1.7 ± 1.1	1.7 ± 1.0
Interval between symptom onset and baseline visit [all patients, days]	3.3 ± 9.8	1.7 ± 1.7
Interval between symptom onset and baseline visit [patients presenting <5 days after symptom onset, days]	1.2 ± 1.4 (n = 185)	1.5 ± 1.4 (n = 141)

POCT, point-of-care testing; SD, standard deviation.